Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$145.6 - $158.88 $214,032 - $233,553
1,470 Added 44.71%
4,758 $745,000
Q3 2023

Oct 24, 2023

BUY
$155.75 - $174.48 $512,106 - $573,690
3,288 New
3,288 $512,000
Q4 2018

Feb 14, 2019

SELL
$122.84 - $147.84 $3.56 Million - $4.28 Million
-28,942 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $413,250 - $485,649
-3,399 Reduced 10.51%
28,942 $4 Million
Q2 2018

Aug 13, 2018

BUY
$119.4 - $131.76 $10,149 - $11,199
85 Added 0.26%
32,341 $3.92 Million
Q1 2018

May 04, 2018

BUY
$125.1 - $148.14 $27,647 - $32,738
221 Added 0.69%
32,256 $4.13 Million
Q3 2017

Nov 09, 2017

BUY
$129.47 - $135.38 $4.15 Million - $4.34 Million
32,035
32,035 $4.17 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $424B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Mandatum Life Insurance CO LTD Portfolio

Follow Mandatum Life Insurance CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mandatum Life Insurance CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Mandatum Life Insurance CO LTD with notifications on news.